Related references
Note: Only part of the references are listed.Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence
Judith S. Knapp et al.
WORLD JOURNAL OF UROLOGY (2013)
Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer
Oscar Rodriguez Faba et al.
CURRENT OPINION IN UROLOGY (2012)
Prostate cancer stem cells: Are they androgen-responsive?
Emma E. Oldridge et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
PRIDE Inspector: a tool to visualize and validate MS proteomics data
Rui Wang et al.
NATURE BIOTECHNOLOGY (2012)
Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens
Lara Tamburrino et al.
STEROIDS (2012)
Terminal Differentiation in Epithelia: The Role of Integrins in Hensin Polymerization
Qais Al-Awqati
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
The bone marrow compartment is modified in the absence of galectin-3
C. Brand et al.
CELL AND TISSUE RESEARCH (2011)
Inmunohistochemical Profile of Solid Cell Nest of Thyroid Gland
Maria Jose Rios Moreno et al.
ENDOCRINE PATHOLOGY (2011)
Prostate Cancer Stem Cells: Do They Have a Basal or Luminal Phenotype?
Norman J. Maitland et al.
Hormones & Cancer (2011)
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
Pratima Nangia-Makker et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
Tsuyoshi Iwata et al.
PLOS ONE (2010)
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Devon A. Lawson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of a Cell of Origin for Human Prostate Cancer
Andrew S. Goldstein et al.
SCIENCE (2010)
Regulation of Prostate Cancer Progression by Galectin-3
Yi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
David J. Mulholland et al.
CANCER RESEARCH (2009)
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Xi Wang et al.
NATURE (2009)
Accumulating Progenitor Cells in the Luminal Epithelial Cell Layer Are Candidate Tumor Initiating Cells in a Pten Knockout Mouse Prostate Cancer Model
Hanneke Korsten et al.
PLOS ONE (2009)
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Bora Gurel et al.
MODERN PATHOLOGY (2008)
Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer
Axel S. Merseburger et al.
PROSTATE (2008)
Galectin-3 in apoptosis, a novel therapeutic target
Pratima Nangia-Makker et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Isolation and functional characterization of murine prostate stem cells
Devon A. Lawson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation
SY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis
XQ Ma et al.
CANCER RESEARCH (2005)
Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies
RM Long et al.
CLINICAL SCIENCE (2005)
Androgen receptor as a target in androgen-independent prostate cancer
SP Balk
UROLOGY (2002)
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
